Clinical Scorecard: Utilizing Endoscopic Vacuum Therapy in the Upper GI Tract: Indications and Application Techniques
At a Glance
Category
Detail
Condition
Transmural wall defects of the esophagus and esophago-gastric junction including anastomotic leakage, iatrogenic perforations, and spontaneous ruptures
Key Mechanisms
Creation of a negatively pressurized compartment promoting wound shrinkage (macro-deformation), granulation tissue formation (micro-deformation), drainage of infected fluids, removal of debris and microorganisms, reduction of interstitial edema, and promotion of angiogenesis
Target Population
Patients with upper gastrointestinal transmural wall defects post-oncological resections, bariatric procedures, iatrogenic or spontaneous perforations
Care Setting
Specialized endoscopic centers, primarily in European centers of expertise
Key Highlights
EVT is increasingly recognized as a standard treatment for foregut wall defects with high success and low complication rates.
Compared to endoscopic stenting, EVT shows higher closure rates, shorter treatment duration, and lower mortality for anastomotic leakage.
Limitations include difficulty in proximal esophagus and gastric fundus/corpus lesions due to inability to establish airtight negative pressure compartments.
Guideline-Based Recommendations
Diagnosis
Identify transmural wall defects of the esophagus and esophago-gastric junction via endoscopy and imaging.
Assess suitability for EVT based on defect location and ability to establish airtight negative pressure environment.
Management
Apply EVT as stand-alone or combined with surgical, endoscopic, or radiological interventions depending on clinical scenario.
Use negative pressure around 125 mmHg to achieve effective macro-deformation and wound cavity shrinkage.
Perform EVT device exchanges every 3–5 days and maintain patients nil by mouth during therapy.
Monitoring & Follow-up
Monitor wound healing progress via endoscopic evaluation of granulation tissue formation and cavity size.
Assess for complications and tolerance to repeated endoscopic procedures and nil per os status.
Risks
Potential intolerance to repeated endoscopic interventions and prolonged nil by mouth status.
Limited applicability in proximal esophagus and large gastric lesions due to inability to maintain sealed negative pressure.
Patient & Prescribing Data
Patients with upper GI transmural defects including post-surgical leaks, iatrogenic and spontaneous perforations
EVT offers higher closure rates and lower mortality compared to stenting, but requires repeated endoscopic exchanges and patient compliance with nil by mouth status.
Clinical Best Practices
Select EVT for transmural esophageal and esophago-gastric junction defects where airtight negative pressure can be established.
Use standardized EVT devices such as EsoSponge® to ensure consistent application and outcomes.
Combine EVT with other interventions as needed based on individual patient condition.
Apply negative pressure around 125 mmHg to optimize wound cavity shrinkage without excessive pressure.
Plan for repeated device exchanges every 3–5 days and manage patient nutrition accordingly.
